Usana Health Sciences annual net debt
2019
2020
2021
2022
2023
2024
2025
Usana Health Sciences Net Debt Growth & History (USNA)
Usana Health Sciences's net debt was −$140.4M for fiscal 2025.
View full Usana Health Sciences company overviewUsana Health Sciences annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2026-01-03 | −$140.4M | $25.1M | — |
| 2024 | 2024-12-28 | −$165.6M | $152.4M | — |
| 2023 | 2023-12-30 | −$318.0M | −$44.2M | — |
| 2022 | 2022-12-31 | −$273.8M | −$51.3M | — |
| 2021 | 2022-01-01 | −$222.5M | $80.8M | — |
| 2020 | 2021-01-02 | −$303.3M | −$94.1M | — |
| 2019 | 2019-12-28 | −$209.2M | — | — |
Usana Health Sciences quarterly net debt
Q1.19
Q2.19
Q3.19
Q4.19
Q4.20
Q4.21
Q4.22
Q4.23
Q4.24
Q1.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-04-04 | −$148.8M | $7.9M | — |
| Q4 2025 | 2026-01-03 | −$140.4M | $25.1M | — |
| Q1 2025 | 2025-03-29 | −$156.6M | — | — |
| Q4 2024 | 2024-12-28 | −$165.6M | $152.4M | — |
| Q4 2023 | 2023-12-30 | −$318.0M | −$44.2M | — |
| Q4 2022 | 2022-12-31 | −$273.8M | −$51.3M | — |
| Q4 2021 | 2022-01-01 | −$222.5M | $80.8M | — |
| Q4 2020 | 2021-01-02 | −$303.3M | −$94.1M | — |
| Q4 2019 | 2019-12-28 | −$209.2M | — | — |
| Q3 2019 | 2019-09-28 | −$163.0M | — | — |
| Q2 2019 | 2019-06-29 | −$211.9M | — | — |
| Q1 2019 | 2019-03-30 | −$206.5M | — | — |
Usana Health Sciences net debt trends
Over the last five fiscal years, Usana Health Sciences's net debt increased from −$303.3M to −$140.4M, a change of $162.9M. The latest reported quarter, Q1 2026, shows −$148.8M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Usana Health Sciences source filings ↗